Back to home
Trust Score: 80%

Trust Score calculated by AI analyzing study rigor, sample size (n), and the scientific source impact factor.

6/4/2026

Enterobactin: The Microbial Metabolite that May Alleviate Colitis

Summary

Enterobactin, a metabolite produced by bacteria, may impair mitochondrial respiration and alleviate colitis

AC
Adrian CastroEditorially reviewed

Adrian Castro created Biohacker Age to have a place to closely follow longevity and biological optimization research without relying on sensationalist headlines. Content is produced with AI assistance from scientific literature and is editorially reviewed before publishing.

About our methodology

Introduction to Enterobactin


Enterobactin is a metabolite produced by bacteria of the Enterobacter genus, which has been recently studied for its possible role in human health. A study published in the PubMed database has found that enterobactin may impair mitochondrial respiration and alleviate colitis. In this article, we will explore the findings of this study and its potential impact on human health.

What is Enterobactin?


Enterobactin is a siderophore, a molecule that binds to iron and transports it to bacteria. It is primarily produced by bacteria of the Enterobacter genus, which are common in the human intestine. Enterobactin has been studied for its possible role in the pathogenesis of bacterial diseases, but its effect on human health is still unknown.

The Effect of Enterobactin on Mitochondrial Respiration


The study published in PubMed has found that enterobactin may impair mitochondrial respiration in human cells. Mitochondrial respiration is the process by which cells produce energy from oxygen and nutrients. Mitochondrial dysfunction has been implicated in several diseases, including colitis.

The Effect of Enterobactin on Colitis


The study also found that enterobactin may alleviate colitis in animal models. Colitis is an inflammatory disease of the intestine that can cause symptoms such as diarrhea, abdominal pain, and weight loss. Enterobactin may reduce inflammation and improve intestinal function in animal models of colitis.

Conclusion


In summary, enterobactin is a microbial metabolite that may impair mitochondrial respiration and alleviate colitis. While the findings of this study are promising, further research is needed to fully understand the effect of enterobactin on human health. Enterobactin may be a potential therapeutic target for the treatment of colitis and other diseases related to mitochondrial dysfunction.

Legal Notice

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended to substitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or supplementation.

Science in your inbox

The most relevant studies of the week, curated and analyzed.

No spam. Unsubscribe anytime.